USE OF THE IMPELLA ECP™ IN PATIENTS UNDERGOING AN ELECTIVE OR URGENT HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION,
Role: Investigator,
ABIOMED, Inc.,
(07/2024 - 07/2025)
Status: Approved
SELUTION SLR™ 014 ISR: A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 Drug Eluting Balloon in the Treatment of Subjects with In-stent Restenosis,
Role: Investigator,
MedAlliance,
(06/2024 - 06/2025)
Status: Approved
A Prospective, Multi-Center, Randomized, Controlled, Single Blind Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class Ill Heart Failure Patients (PROACTIVE- HF Trial),
Role: PI,
Endotronix, Inc.,
(01/2025 - 01/2026)
Status: Approved
Impella®-Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial,
Role: Investigator,
ABIOMED, Inc.,
(01/2025 - 01/2026)
Status: Approved
Equity in Modifying Plaque Of WomEn with UndeRtreated Calcified Coronary Artery Disease (EMPOWER CAD),
Role: Investigator,
Shockwave Medical, Inc.,
(11/2023)
Status: Approved